ArticleClinical and molecular hepatology2016

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol SongPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.